Driving a return to normal life
AbC-19™ is a rapid antibody test used for the detection of SARS-CoV-2 (COVID-19) neutralising antibodies in response to infection or following vaccination.
Detect SARS-CoV-2 neutralising antibodies from a small finger prick of blood in only 20 minutes.
Show whether someone has produced an immune response to COVID-19 infection or vaccination in multiple testing locations.
Boxes of 25 tests at £250.00+VAT per kit.
AbC-19™ is a lateral flow test CE marked for use by healthcare professionals across the UK and EU.
The AbC-19™ Antibody Rapid Test can be deployed across populations and has the potential to inform vaccination programmes and health policy by showing:
- How COVID-19 infection spreads through communities
- Where and why immunity to COVID-19 might be developing
- How mass-immunisation campaigns could be designed
Why use AbC-19™ Rapid Test?
- Confirms the presence of SARS-CoV-2 IgG neutralising antibodies in a small blood sample
- Sensitivity: 98.03%, Specificity: 99.56%*
- Minimal operator training required
- CE marked for use by healthcare professionals
- For use in multiple testing locations such as workplaces, pharmacies or doctors’ surgeries
24/7 customer support helpline
AbC-19™ Rapid Test and vaccines
Vaccines “train” the immune system by using harmless viruses that have been altered to resemble dangerous ones. In the case of SARS-CoV-2 vaccine developers have focused on mimicking the Spike protein. Three of the leading vaccine candidates all feature full-length SARS-CoV-2 spike trimers: Oxford University / AstraZeneca, Pfizer / BioNTeh, and Moderna.
Professor Lawrence S. Young, Virologist at University of Warwick Medical School:
”The AbC-19™ Rapid Test targets the IgG antibodies to the full spike protein of the SARS-CoV-2 virus and therefore has the potential to help identify the immune system’s response to the current three Medicines and Healthcare products Regulatory Agency (MHRA) approved vaccines.
The assay could help establish whether people’s immune systems are responding to the vaccine in the right way, and, ultimately, could be predictive of a protective immune response”
25 x AbC-19™ Rapid Tests
30 x Lancets
30 x Test Solution Vials (containing 30 units)
30 x Blood Collectors
25 x Waste Bags
1 x IFU (Instructions for Use)
Healthcare professionals from the UK and Europe Union can order the AbC-19™ rapid antibody test. The antibody test is for sale via Abingdon Health’s website. Order here.
Abingdon Health accepts payment in GBP and EUR via BACS, Credit Card or Debit Card. Phone orders can be made at +44 (0) 1904 406082.
From the point of payment shipments normally take 2 to 5 days to complete. All shipments are tracked. Please contact our team if you have urgent shipping needs.
Shipping is charged dependent on the size of your order and is in addition the advertised test price. Our team will confirm shipping costs and details prior to payment.
The SARS-CoV-2 IgG antibody test is CE marked for professional use by healthcare professionals, such as doctors, nurses, pharmacists and healthcare workers, and meets UK and European Union (EU) health and safety requirements. Laboratory professionals or trained lay providers may use the test.
The test cannot be used by anyone else.
If you would like to order our rapid antibody test, please visit this page.
If taken at least 14 days following the onset of symptoms then the AbC-19™ Rapid Test has a sensitivity of 98.03% and a specificity of 99.56%. More details here.
As detailed in the table below a known population of 450 negative samples were tested alongside 203 known positive samples. The positive population of 203 samples were obtained from donors at least 14 days after the onset of COVID-19 symptoms and were verified as positive using a commercial IgG SARS-CoV-2 ELISA kit.
Positive Negative ELISA Positive 199 4 Negative 2^ 448*
* 98 pre-pandemic negative samples not tested by ELISA
^ 2 pre-pandemic negative samples not tested by ELISA
Clinical Sensitivity and Specificity is as follows:
Positive Predictive Agreement (Sensitivity): 98.03% (95% Cla : 95.03% – 99.46%)
Negative Predictive Agreement (Specificity): 99.56% (95% Cla : 98.40% – 99.95%)
Known positive serum samples from other viral infections were tested as follows (value in square brackets refers to the number tested) Seasonal Coronavirus (HCoV-NL63 [x5] and HCoV-229E [x5]), Influenza A [x5], H5N1 Influenza [x1], influenza B [x6] Respiratory Syncytial Virus (RSV) [x6], Haemophilus influenzae type b [x5] and Bordetella pertussis [x1]. No cross reactivity was observed, with all tests demonstrating a negative result using the AbC-19™ Rapid Test.
Interference: A range of substances were tested using the AbC-19™ Rapid Test for positive and negative interference. No false positives or false negatives were recorded at the concentrations in the table below;
Substance Upper limit of normal serum levels mg/dL Level Tested mg/dL Unconjugated Bilirubin 2 40 Cholesterol (total) <200 400 Triglyceride 200 1,500 IgG 1,400 4,200 IgM 250 750 Haemoglobin 17.5 1,000 Biotin 0.117 0.351 Acetaminophen (paracetamol) 5.2 15.6 Acetylsalicylic acid (asprin) 1 3 Ibuprofen 7.3 22 Caffeine 3.6 11
From a finger-prick sample of blood, AbC-19™ antibody rapid test detects the SARS-CoV-2 IgG neutralising antibodies to the full spike protein produced in response to the virus or following vaccination. The rapid antibody test will determine if the body has produced a measurable immune response indicating a previous infection with COVID-19 virus or vaccination. It will not confirm if you are currently infected by the virus.
The line closest to the sample hole is the test line (T-line). The presence of a T-line alongside a C-line is a POSITIVE result, the absence of a T-Line alongside a C-line is a NEGATIVE result.